StockData
Phio Pharmaceuticals Corp. logo

Phio Pharmaceuticals Corp. (PHIO) stock

PHIONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$0.72−0.04 (-4.65%)

Close on Nov 17, 2026Market cap $8.33MP/E –Yield –

Phio Pharmaceuticals profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Phio Pharmaceuticals's profit margin for the twelve months ending Dec 31, 2019 was -42419.0%. For fiscal 2019 it was -42419.0%, against -5333.3% the year before. The highest annual figure on record is -5244.4% in fiscal 2013.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2019Dec 31, 2019-42419.0%−37085.7
FY2018Dec 31, 2018-5333.3%+77680.0
FY2017Dec 31, 2017-83013.3%−35676.5
FY2016Dec 31, 2016-47336.8%−17269.2
FY2015Dec 31, 2015-30067.6%−24823.3
FY2013Dec 31, 2013-5244.4%+8034.0
FY2012Dec 31, 2012-13278.4%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2019Mar 31, 2019-10090.5%+3256.2
Q3 FY2018Sep 30, 2018-2619.3%–
Q2 FY2018Jun 30, 2018-3277.6%–
Q1 FY2018Mar 31, 2018-9734.8%–
Q4 FY2017Dec 31, 2017-13346.7%–

More Phio Pharmaceuticals figures

See a number that looks wrong?